Cassava Sciences stock plummeted Monday — wiping out more than three-quarters of its value — after the company's Alzheimer's treatment failed in Phase 3 testing. Please watch the video at ...

Cassava Sciences' troubled development of ... Meanwhile, former Cassava CEO Remi Barbier and ex-head of neuroscience Dr Lindsay Burns settled for $175,000 and $85,000, respectively.

Cassava Sciences is working on bringing its own ... which led the SEC to allege that the company and its former CEO, Remi Barbier, misled investors. In addition, the company did not disclose ...

AUSTIN, Texas - Cassava Sciences, Inc. (NASDAQ: SAVA), a biotech firm specializing in treatments for central nervous system disorders, announced today the upcoming retirement of its Chief Medical ...

Cassava Sciences (SAVA) announced the retirement of James Kupiec, chief medical officer, effective May 9. The company also appointed Jack Moore as senior VP, clinical development, reporting to ...

Cassava Sciences said its chief medical officer, Dr. James Kupiec, is retiring, effective May 9. Under Kupiec, the clinical-stage biotechnology company completed a clinical trial program in ...

Le 15 avril 2025, Cassava Sciences, Inc. a annoncé que James W. Kupiec, M.D., avait fait part de son intention de prendre sa retraite et avait présenté sa démission en tant que directeur ...

Cassava Sciences doit faire face à un procès pour poursuite abusive concernant un médicament contre la maladie d'Alzheimer 26/03 RE Les marchés boursiers clôturent en hausse, les faibles ...

AUSTIN, Texas - Cassava Sciences, Inc. (NASDAQ: SAVA), a biotech firm specializing in treatments for central nervous system disorders, announced today the upcoming retirement of its Chief Medical ...

SAVA DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 10 Deadline in Securities ...

CASSAVA SCIENCES, INC. : HC Wainwright révise son opinion et passe à neutre 26/11 ZM CASSAVA SCIENCES, INC. : HC Wainwright passe de neutre à achat 08/10/24 ZM CASSAVA SCIENCES, INC. : HC ...